Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pembroke

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACG Case Reports Journal|November 2, 2016
Fibrofatty Band-Associated Small Bowel Obstruction After Marathon RunningTom Pembroke, Lawrence Sunder Raj
Journal of Immunological Methods|April 28, 2015
Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liverTom Pembroke, Awen Gallimore, Andrew Godkin
Journal of Hepatology|June 25, 2013
Flow cytometry makes all the differenceTom Pembroke, Awen Gallimore, Andrew Godkin
Physiology & Behavior|November 28, 2025
Emotional eating and metabolic dysfunction-associated steatotic liver disease (MASLD): a pre-registered study in a clinical populationMarisol Vazquez, Laura L Wilkinson, Tom Pembroke
Gut|May 14, 2013
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatmentTom Pembroke, Adam Christian, Emma Jones, et al.
British Journal of Haematology|December 23, 2025
Guideline for the management of hepatitis B and C infection and subsequent liver disease surveillance (where indicated) in people with congenital bleeding disorders: A joint guideline from the British Society of Haematology and the British Viral Hepatitis GroupAshley Brown, Richard J Aspinall, Stephen T Barclay, et al.
European Journal of Immunology|June 2, 2012
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunityTom Pembroke, Ian Rees, Kathleen Gallagher, et al.
Cancer Immunology Research|January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapyMartin Scurr, Anja Bloom, Tom Pembroke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal CancerMartin Scurr, Tom Pembroke, Anja Bloom, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACG Case Reports Journal|November 2, 2016
Fibrofatty Band-Associated Small Bowel Obstruction After Marathon RunningTom Pembroke, Lawrence Sunder Raj
Journal of Immunological Methods|April 28, 2015
Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liverTom Pembroke, Awen Gallimore, Andrew Godkin
Journal of Hepatology|June 25, 2013
Flow cytometry makes all the differenceTom Pembroke, Awen Gallimore, Andrew Godkin
Physiology & Behavior|November 28, 2025
Emotional eating and metabolic dysfunction-associated steatotic liver disease (MASLD): a pre-registered study in a clinical populationMarisol Vazquez, Laura L Wilkinson, Tom Pembroke
Gut|May 14, 2013
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatmentTom Pembroke, Adam Christian, Emma Jones, et al.
British Journal of Haematology|December 23, 2025
Guideline for the management of hepatitis B and C infection and subsequent liver disease surveillance (where indicated) in people with congenital bleeding disorders: A joint guideline from the British Society of Haematology and the British Viral Hepatitis GroupAshley Brown, Richard J Aspinall, Stephen T Barclay, et al.
European Journal of Immunology|June 2, 2012
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunityTom Pembroke, Ian Rees, Kathleen Gallagher, et al.
Cancer Immunology Research|January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapyMartin Scurr, Anja Bloom, Tom Pembroke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal CancerMartin Scurr, Tom Pembroke, Anja Bloom, et al.
JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.
Pageof 1